Optimal Pre-dilatation Treatment before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis. The OPTIMIS trial
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
Bioresorbable scaffolds (BRS) have been developed to overcome limitations related to late stent failures of drug-eluting-stents, but previous studies have observed lumen reduction over time after implantation of BRS. The aim of the study was to investigate if lesion preparation with a scoring balloon compared to a standard non-compliant balloon minimizes lumen reduction after implantation of a Magmaris BRS (MgBRS) assessed with optical coherence tomography (OCT) and intravascular ultrasound (IVUS).
Method
Eighty-two patients with stable angina pectoris were included and randomized in a ratio 1:1 to lesion preparation with either a scoring balloon or a standard non-compliant balloon prior to implantation of a MgBRS. The primary endpoint was minimal lumen area (MLA) 6 months after MgBRS implantation.
Results
Following MgBRS implantation, MLA (6.4 ± 1.6 mm 2 vs. 6.3 ± 1.5 mm 2 , p=0.65), mean scaffold area (7.8 ± 1.5 mm 2 vs. 7.5 ± 1.7 mm 2 , p=0.37), and mean lumen area (8.0 ± 1.6 mm 2 vs. 7.7 ± 2.1 mm 2 , p=0.41) did not differ significantly in patients where the lesions were prepared with scoring vs. standard non-compliant balloon respectively. Six-month angiographic follow-up with OCT and IVUS was available in seventy-four patients. The primary endpoint, 6-months MLA, was significantly larger in lesions prepared with a scoring balloon compared to a standard non-compliant balloon (4.7 ± 1.4 mm 2 vs. 3.9 ± 1.9 mm 2 , p=0.04), whereas mean lumen area (7.2 ± 1.4 mm 3 vs. 6.8 ± 2.2, p=0.35) did not differ significantly. IVUS findings showed no difference in mean vessel area at the lesion site from baseline to follow-up in the scoring balloon group (16.8 ± 2.9 mm 2 vs. 17.0 ± 3.6 mm 2 , p=0.62), whereas mean vessel area (17.1 ± 4.4 mm 2 vs. 15.7 ± 4.9 mm 2 , p<0.001) was smaller in lesions prepared with a standard non-compliant balloon due to negative remodeling.
Conclusion
Lesion preparation with a scoring balloon prior to implantation of a MgBRS resulted in significantly larger MLA after 6 months due to less negative remodeling compared to lesion preparation with a standard non-compliant balloon.
Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04666584 .
Clinical perspectives
What is new?
- Intense lesion preparation with a scoring balloon prior to implantation of a magnesium-based Magmaris bioresorbable scaffold results in less lumen reduction and malapposition after 6 month compared to conventional lesion preparation with a non-compliant balloon in patients with stable angina.
- Negative remodeling was seen in lesions treated with conventional lesion preparation, whereas optimal lesion preparation with a scoring balloon caused in stable remodeling.
- Lesions preparation with a scoring balloon is safe and ensures better vascular healing and vessel dynamics after implantation of a magnesium-based Magmaris bioresorbable scaffold.
- Optimal lesion preparation should be considered before implantation of magnesium-based Magmaris bioresorbable scaffold.
